Literature DB >> 12091507

Antiphospholipid syndrome.

Sanjay C Keswani1, Naresh Chauhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12091507      PMCID： PMC1279937          DOI： 10.1177/014107680209500705

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  58 in total

1.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

Authors:  M Galli; P Comfurius; C Maassen; H C Hemker; M H de Baets; P J van Breda-Vriesman; T Barbui; R F Zwaal; E M Bevers
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

2.  Antiphospholipid antibodies and cerebral ischemia in young people.

Authors:  R L Brey; R G Hart; D G Sherman; C H Tegeler
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

3.  Syndrome of the black swan.

Authors:  E N Harris
Journal:  Br J Rheumatol       Date:  1987-10

4.  Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.

Authors:  K Lechner; I Pabinger-Fasching
Journal:  Haemostasis       Date:  1985

5.  Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.

Authors:  W H Kutteh
Journal:  Am J Obstet Gynecol       Date:  1996-05       Impact factor: 8.661

6.  Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis.

Authors:  R A Levy; A E Gharavi; L R Sammaritano; L Habina; T Qamar; M D Lockshin
Journal:  J Rheumatol       Date:  1990-08       Impact factor: 4.666

7.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

Authors:  H P McNeil; R J Simpson; C N Chesterman; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus.

Authors:  D T Boumpas; S Barez; J H Klippel; J E Balow
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

9.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

10.  The relationship between lupus anticoagulants and antibodies to phospholipid.

Authors:  D A Triplett; J T Brandt; K A Musgrave; C A Orr
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272
View more
  6 in total

Review 1.  Anti-phospholipid Antibodies and Smoking: An Overview.

Authors:  Steven R Binder; Christine M Litwin
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

2.  Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review.

Authors:  Mandana Khodashahi; Zahra Rezaieyazdi; Maryam Sahebari
Journal:  Arch Rheumatol       Date:  2019-12-12       Impact factor: 1.472

Review 3.  Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age.

Authors:  Bogna Grygiel-Górniak; Nattakarn Limphaibool; Mariusz Puszczewicz
Journal:  Prz Menopauzalny       Date:  2018-06-30

4.  Prevalence and Clinical Significance of Antiphospholipid Antibodies in Hospitalized Patients With COVID-19 Infection.

Authors:  Navkirat Kahlon; Pejma Shazadeh Safavi; Ziad Abuhelwa; Taha Sheikh; Cameron Burmeister; Sishir Doddi; Ragheb Assaly; William Barnett
Journal:  Cureus       Date:  2022-08-10

5.  Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies.

Authors:  Carlos Tortosa; Oscar Cabrera-Marante; Manuel Serrano; José A Martínez-Flores; Dolores Pérez; David Lora; Luis Morillas; Estela Paz-Artal; José M Morales; Daniel Pleguezuelo; Antonio Serrano
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

6.  Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report.

Authors:  Andris Skride; Matiss Sablinskis; Kristaps Sablinskis; Sandra Lejniece; Aivars Lejnieks; Walter Klepetko; Irene M Lang
Journal:  Am J Case Rep       Date:  2018-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.